Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Oilminerdeluxeon Nov 17, 2024 8:43am

230 Views

Post# 36316993

PP done

The PP is done. Perhaps they are ready for other releases soon then. How about next week, eh? Or we wait until the next Q report. Anyway, it appears that we are nearing a crucial point in the company's history. Hopefully, it will be a good one. If they have sent in the application, Christmas could still be sweet. I know IR reads SH from time to time, so fingers crossed for some positive action.

<< Previous

Bullboard Posts

Next >>

BlackBerry partners with Avathon to enhance critical event management with AI